Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
53
CATX Quote, Financials, Valuation and Earnings
Last price:
$2.8800
Seasonality move
:
28.22%
Day range:
$2.7050 - $2.8200
52-week range:
$1.6000 - $5.3881
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
190.53x
P/B ratio:
0.86x
Volume:
512.9K
Avg. volume:
1.8M
1-year change:
-13.54%
Market cap:
$208.9M
Revenue:
$1.5M
EPS (TTM):
-$1.46
Earnings Data
Next earnings date for CATX
Mar 26
2026
Most recent earnings per share
-$0.35
Missed by $0.03
(Nov 10/2025)
Consensus Estimate
-$0.32
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CATX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/26/2026 | Q4 | $211.4K | -- | -- | -$0.35 | -- |
| 11/10/2025 | Q3 | $206.8K | $209K | -$0.35 | -$0.32 | -$0.03 |
| 08/13/2025 | Q2 | $170.4K | $290K | -$0.29 | -$0.29 | $0.00 |
| 05/12/2025 | Q1 | $143.9K | $342K | -$0.25 | -$0.27 | $0.02 |
| 03/26/2025 | Q4 | $277.3K | $234K | -$0.57 | -$0.25 | -$0.32 |
| 11/12/2024 | Q3 | $237.9K | $369K | -$0.21 | -$0.20 | -$0.01 |
| 08/12/2024 | Q2 | $135.6K | $526K | -$0.18 | -- | -- |
| 05/15/2024 | Q1 | $68.8K | $325K | -$0.25 | -- | -- |
| 03/28/2024 | Q4 | $2.1M | -- | -- | -- | -- |
| 11/14/2023 | Q3 | -- | $276K | -$0.37 | -- | -- |
| 08/11/2023 | Q2 | -- | $588K | -$0.40 | -- | -- |
| 05/16/2023 | Q1 | -- | $233K | -$0.02 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.02 | -- | -- |
| 11/10/2022 | Q3 | -- | $1.7M | -$0.30 | -- | -- |
| 06/30/2022 | Q2 | -- | $2.5M | -$0.15 | -- | -- |
| 03/31/2022 | Q1 | -- | $2.9M | -$0.09 | -- | -- |
| 12/31/2021 | Q4 | -- | $2.8M | -$0.11 | -- | -- |
| 09/30/2021 | Q3 | -- | $2.6M | -$0.16 | -- | -- |
| 06/30/2021 | Q2 | -- | $2.7M | -$0.07 | -- | -- |
| 03/31/2021 | Q1 | -- | $2.6M | -$0.06 | -- | -- |
| 12/31/2020 | Q4 | -- | $2.4M | -$0.10 | -- | -- |
| 09/30/2020 | Q3 | -- | $2.4M | -$0.10 | -- | -- |
| 06/30/2020 | Q2 | -- | $2.3M | -$0.18 | -- | -- |
| 03/31/2020 | Q1 | -- | $2.9M | -$0.08 | -- | -- |
| 12/31/2019 | Q4 | -- | $2.2M | -$0.13 | -- | -- |
| 09/30/2019 | Q3 | -- | $2.3M | -$0.12 | -- | -- |
| 06/30/2019 | Q2 | -- | $1.9M | -$0.16 | -- | -- |
| 03/31/2019 | Q1 | -- | $1.9M | -$0.17 | -- | -- |
| 12/31/2018 | Q4 | -- | $1.9M | -$0.21 | -- | -- |
| 09/30/2018 | Q3 | -- | $1.6M | -$0.23 | -- | -- |
| 06/30/2018 | Q2 | -- | $1.6M | -$0.40 | -- | -- |
| 03/31/2018 | Q1 | -- | $1.6M | -$0.20 | -- | -- |
| 12/31/2017 | Q4 | -- | $1.5M | -$0.30 | -- | -- |
| 09/30/2017 | Q3 | -- | $1.2M | -$0.30 | -- | -- |
| 06/30/2017 | Q2 | -- | $1.4M | -$0.30 | -- | -- |
| 03/31/2017 | Q1 | -- | $1.3M | -$0.20 | -- | -- |
| 12/31/2016 | Q4 | -- | $1M | -$0.30 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.1M | -$0.30 | -- | -- |
| 06/30/2016 | Q2 | -- | $1.1M | -$0.20 | -- | -- |
| 03/31/2016 | Q1 | -- | $1.2M | -$0.20 | -- | -- |
| 12/31/2015 | Q4 | -- | $1.2M | -$0.20 | -- | -- |
Perspective Therapeutics, Inc. Earnings Questions
-
How Much did Perspective Therapeutics, Inc. Generate in Revenue Last Quarter?
Perspective Therapeutics, Inc. reported $209K worth of top line sales in its most recent quarter.
-
Did Perspective Therapeutics, Inc. Beat Earnings Last Quarter?
Perspective Therapeutics, Inc. announced earnings per share of -$0.35 which represents a miss of analyst forecast a -$0.32 per share.
-
Is Perspective Therapeutics, Inc. Profitable?
Perspective Therapeutics, Inc. reported -$566K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Perspective Therapeutics, Inc. EPS Next Year?
Perspective Therapeutics, Inc.'s earnings are forecast to decrease from -$1.23 per share to -$0.76 per share next year representing a decrease of -1.45%.
-
When is Perspective Therapeutics, Inc.'s Earnings Date?
Perspective Therapeutics, Inc.'s next earnings date is March 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
GLTO alert for Dec 26
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Sell
27
CDNAF alert for Dec 26
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
